Towards Zero Thromboembolic Events After Bariatric Metabolic Surgery

Obesity increases the risk of developing venous thromboembolic disease (VTE), including deep vein thrombosis (DVT), pulmonary embolism (PE), and portomesenteric vascular thrombosis (PMVT). Despite the widespread application of laparoscopy in bariatric metabolic surgery (BMS), VTE is still encountered, with the incidence of symptomatic DVT, PE, and PMVT ranging from 0.2 to 3%, 0.1 to 2%, and 0.3% to 1%, respectively. We provide a brief communication on the current evidence and guidelines derived from our opinion formulated after 15 years of practice and, thereby, postulate novel suggestions for a new regimen.